Business Description
OptimizeRx Corp
NAICS : 621610
SIC : 8099
ISIN : US68401U2042
Description
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.42 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | -1.96 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 1.71 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.7 | |||||
3-Year EBITDA Growth Rate | -577.5 | |||||
3-Year EPS without NRI Growth Rate | -68 | |||||
3-Year FCF Growth Rate | -3 | |||||
3-Year Book Growth Rate | 28.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 11.5 | |||||
Future 3-5Y Total Revenue Growth Rate | 25.8 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.27 | |||||
9-Day RSI | 27.61 | |||||
14-Day RSI | 34.05 | |||||
6-1 Month Momentum % | -12.21 | |||||
12-1 Month Momentum % | -17.46 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.88 | |||||
Quick Ratio | 2.88 | |||||
Cash Ratio | 0.91 | |||||
Days Sales Outstanding | 115.08 | |||||
Days Payable | 15.99 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.1 | |||||
Shareholder Yield % | -9.92 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.95 | |||||
Operating Margin % | -19.8 | |||||
Net Margin % | -23.1 | |||||
FCF Margin % | -7.46 | |||||
ROE % | -14.93 | |||||
ROA % | -12.26 | |||||
ROIC % | -11.99 | |||||
ROC (Joel Greenblatt) % | -116.7 | |||||
ROCE % | -15.89 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 28.06 | |||||
PS Ratio | 2.23 | |||||
PB Ratio | 1.48 | |||||
EV-to-EBIT | -9.42 | |||||
EV-to-EBITDA | -10.94 | |||||
EV-to-Revenue | 2.61 | |||||
EV-to-Forward-Revenue | 2.01 | |||||
EV-to-FCF | -34.96 | |||||
Price-to-Projected-FCF | 2.08 | |||||
Price-to-Median-PS-Value | 0.5 | |||||
Earnings Yield (Greenblatt) % | -10.62 | |||||
FCF Yield % | -3.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OPRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OptimizeRx Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 78.208 | ||
EPS (TTM) ($) | -1.03 | ||
Beta | 1.34 | ||
Volatility % | 81.23 | ||
14-Day RSI | 34.05 | ||
14-Day ATR ($) | 0.499801 | ||
20-Day SMA ($) | 10.7385 | ||
12-1 Month Momentum % | -17.46 | ||
52-Week Range ($) | 6.92 - 16.645 | ||
Shares Outstanding (Mil) | 18.27 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
OptimizeRx Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
OptimizeRx Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
OptimizeRx Corp Frequently Asked Questions
What is OptimizeRx Corp(OPRX)'s stock price today?
The current price of OPRX is $10.00. The 52 week high of OPRX is $16.65 and 52 week low is $6.92.
When is next earnings date of OptimizeRx Corp(OPRX)?
The next earnings date of OptimizeRx Corp(OPRX) is 2024-08-14 Est..
Does OptimizeRx Corp(OPRX) pay dividends? If so, how much?
OptimizeRx Corp(OPRX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |